Adapthealth's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Adapthealth's ROI in the second quarter of 2026?
Adapthealth Corp recorded a cumulative net loss of $-223 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -6.09%.

Within the Healthcare sector 225 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 2707, from total ROI ranking in the first quarter of 2026 at 3099.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-5.13 %	-5.65 %	-5.44 %	-3.77 %	-4.64 %
Y / Y Net Income Change TTM	-	-	-	95.35 %	314.53 %
Investment (TTM) in Millions	3,639	3,688	3,612	3,721	3,735
Return On Investment (TTM)	-6.09 %	-2.03 %	-1.77 %	2.28 %	2.2 %
AHCO's Overall Ranking	# 2707	# 3099	# 2010	# 1879	# 1798
Seq. Investment Change TTM	-0.65 %	-1.2 %	-2.07 %	-1.32 %	-1.19 %
Seq. Net Income Change TTM	-	-	-	2.11 %	-5.24 %
Net Income (TTM) in Millions	-223	-75	-66	87	85

AHCO Company Profile >> Back to AHCO Roi Comparisons >> See Annual AHCO Return On Investment

Return On Investment AHCO's Ranking
Within:	No.
Industry	# 25
Sector	# 226
Overall	# 2707

Return On Investment Statistics
High	Average	Low
4.32 %	-7.55 %	-55.09 %
(Mar 31 2022)		(Mar 31 2020)

Financial Statements
Adapthealth's II. Quarter Investments	$ 3,639 Millions	AHCO's Balance sheet
Adapthealth's II. Quarter Income	$ -133 Millions	Quarterly AHCO's Income Statement
AHCO's Income by Division		See AHCO's Income by Division

AHCO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	3,612	3,927	3,980	4,770	4,755
Y / Y Investment Growth	-8.02 %	-1.33 %	-16.56 %	0.31 %	260.98 %
Net Income in Millions	-66	95	-675	73	158
Y / Y Net Income Growth	-	-	-	-53.76 %	-
Annual Return On Investment	-1.83 %	2.41 %	-16.95 %	1.53 %	3.33 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AHCO's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AHCO's Competitors
Subscribers only: Roi for Adapthealth's Suppliers
Subscribers only: Return On Investment for AHCO's Customers

Other Ratios
AHCO's Roa	AHCO's Inventory Turnover Ratio	AHCO's Growth Rates	AHCO's Dividend Statistics
	AHCO's Profitability Ratios	AHCO's Asset Turnover Ratio	AHCO's Dividend Growth
AHCO's Roe	AHCO's Valuation Ratios	AHCO's Financial Strength Ratios	AHCO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:37:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.